Workflow Efficiency from Using Dry Reagents
Laboratory staff are spending the majority of their time on tasks such as cocktailing, reagent quality control (QC), and inventory management. This leaves insufficient time for your highly skilled staff to:
- Adapt new technology
- Increase time on data interpretation
- Increase your test throughput
- Expand your menu offering
Many labs have now accepted and recognized this challenge and want to ensure minimal reagent waste, which would can save money and time. Labs also want to manage routine tasks efficiently so that they can use employee time more effectively.
Leukemia and Lymphoma
-
Leukemia and Lymphoma
- B Cell Malignancies
- Minimizing Waste in Flow Cytometry Workflows
- T Cell Malignancies
- Myeloid Malignancies
- CD200 Expression in B-lineage Neoplasms
- Importance of CD34 in Screening Tests for Hematolymphoid Neoplasms: ClearLLab LS Shows the Way
- Utilization of the ClearLLab lymphoid screening tube for investigation of hematolymphoid neoplasias by flow cytometry
- Demonstration of the Clinical Performance of the ClearLLab LS in a Multi-Center Study
- Performance Testing of the ClearLLab LS (Lymphoid Screen)*
- Standardized Compensation Setup for the ClearLLab 10C Application
- ClearLLab Control Cells – a Process Control for ClearLLab 10C Application
- Download the Immunophenotyping Reference Table for Hematopoietic Malignancies
- ClearLLab 10-Color Panel Performance: Lot-to-Lot Reproducibility
- ClearLLab 10C Panel Markers and how they are combined
- Standardized reagents and guidelines for the immunophenotyping of hematologic neoplasms by flow cytometry
- DURA Innovations Cost Benefit Calculator
- Leukemia and lymphoma: an example of how flow cytometry aids diagnosis
- Workflow Efficiency from Using Dry Reagents
- Dry Versus Liquid Antibody Reagents
-
Meet the Experts
- Panel Design and Marker Combinations of ClearLLab 10C
- ClearLLab LS Webinar
- Interpretation of Flow Cytometry for Leukemia and Lymphoma Diagnosis
- Meet the Expert on the ClearLLab 10C System
- Meet The Experts on ClearLLab LS Lymphoid Screen Antibody Panel
- Meet The Experts on DURA Innovation Dry Reagent Technology
-
Standardized Results - Clinical Vignettes
- The ClearLLab 10C Casebook
- Download your FREE e-Casebook: ClearLLab 10C Panels
- Download your FREE e-Casebook: ClearLLab 10C Panels
- Case 2: Chronic lymphocytic leukemia/small lymphocytic lymphoma
- Case 3: B-lymphoblastic leukemia/lymphoma
- Case 4: B Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
- Case 5: T-Lymphoblastic Leukemia/Lymphoma
- Case 7: Acute myeloid leukemia
- Case 7: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Case 14: T Lymphoblastic Leukemia/ T Lymphoblastic Lymphoma
- Case 16: T-Cell Lymphoproliferative Disorder
- Case 18: Acute Myeloid Leukemia
- Case 22: Acute Monocytic Leukemia
- FREE e-Casebook: ClearLLab LS Lymphoid Screen Reagent
- ClearLLab LS Lymphoid Screen Casebook
- Global Health